Catalio Capital Management, LP 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Catalio Capital Management, LP disclosed 40 US equity positions worth $476.9m in its Q2 2025 13F filing. The largest position was LLY at 8.8% of the reported book, followed by BBIO and SLNOEUR. Against the Q1 2025 filing, it opened 13 new positions, added to 8 and reduced 13 among the top 40 holdings.
What did Catalio Capital Management, LP own in Q2 2025? Top 40 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & CO | Healthcare | 8.8% | $42.0m | 53,916 | 128% | added |
| 2 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 8.4% | $40.1m | 927,711 | -4% | reduced |
| 3 | SLNOEUR SOLENO THERAPEUTICS INC | 7.2% | $34.3m | 409,944 | 155% | added | |
| 4 | ASND ASCENDIS PHARMA A/S | Healthcare | 6.5% | $31.1m | 179,926 | -8% | reduced |
| 5 | ISRG INTUITIVE SURGICAL INC | Healthcare | 6.5% | $30.8m | 56,674 | 55% | added |
| 6 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 6.4% | $30.6m | 390,932 | -10% | reduced |
| 7 | GILD GILEAD SCIENCES INC | Healthcare | 5.3% | $25.2m | 226,875 | – | new |
| 8 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 5.2% | $24.6m | 229,046 | – | new |
| 9 | CYTK CYTOKINETICS INC | Healthcare | 4.2% | $19.9m | 601,439 | 3% | added |
| 10 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 4.1% | $19.7m | 2,104,512 | 21% | added |
| 11 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 4.1% | $19.6m | 1,170,372 | – | new |
| 12 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 3.7% | $17.6m | 239,125 | – | new |
| 13 | NTRA NATERA INC | Healthcare | 3.4% | $16.4m | 97,297 | – | new |
| 14 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 3.4% | $16.3m | 1,396,445 | 128% | added |
| 15 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 2.9% | $13.9m | 746,527 | -2% | reduced |
| 16 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 2.9% | $13.9m | 670,575 | -5% | reduced |
| 17 | ADMA ADMA BIOLOGICS INC | Healthcare | 2.2% | $10.4m | 569,704 | – | new |
| 18 | HALO HALOZYME THERAPEUTICS INC | Healthcare | 2.1% | $10.0m | 191,529 | – | new |
| 19 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.6% | $7.8m | 213,402 | – | new |
| 20 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 1.6% | $7.7m | 162,596 | 42% | added |
| 21 | PHAT PHATHOM PHARMACEUTICALS INC | 1.4% | $6.4m | 672,290 | – | new | |
| 22 | QURE UNIQURE NV | 1.2% | $5.8m | 417,443 | -50% | reduced | |
| 23 | WGS GENEDX HOLDINGS CORP | Healthcare | 1.2% | $5.7m | 61,507 | – | new |
| 24 | TARA PROTARA THERAPEUTICS INC | 1.0% | $4.9m | 1,626,370 | 49% | added | |
| 25 | OM OUTSET MED INC | 0.7% | $3.2m | 166,666 | 0% | held | |
| 26 | SEPN SEPTERNA INC | 0.7% | $3.1m | 294,360 | -71% | reduced | |
| 27 | REPL REPLIMUNE GROUP INC | Healthcare | 0.6% | $3.1m | 330,337 | -7% | reduced |
| 28 | ZBIO ZENAS BIOPHARMA INC | 0.4% | $2.1m | 215,314 | -27% | reduced | |
| 29 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 0.4% | $2.0m | 388,303 | -37% | reduced |
| 30 | KYTX KYVERNA THERAPEUTICS INC | 0.4% | $1.8m | 586,909 | 0% | held | |
| 31 | IRON DISC MEDICINE INC | Healthcare | 0.3% | $1.6m | 30,661 | – | new |
| 32 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.3% | $1.3m | 188,304 | -7% | reduced |
| 33 | BCAX BICARA THERAPEUTICS INC | 0.2% | $908.6k | 97,800 | – | new | |
| 34 | MGX METAGENOMI INC | 0.2% | $782.9k | 528,993 | 0% | held | |
| 35 | KPTI KARYOPHARM THERAPEUTICS INC | 0.1% | $629.3k | 146,013 | -6% | reduced | |
| 36 | HYPR HYPERFINE INC | 0.1% | $546.9k | 760,035 | 0% | held | |
| 37 | MERSANA THERAPEUTICS INC | 0.1% | $464.0k | 1,567,413 | -8% | reduced | |
| 38 | ATAI LIFE SCIENCES NV | 0.1% | $431.1k | 196,858 | 0% | held | |
| 39 | GUTS FRACTYL HEALTH INC | 0.1% | $347.1k | 214,236 | 0% | held | |
| 40 | FTH SENSEI BIOTHERAPEUTICS INC | 0.0% | $126.3k | 14,718 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.